Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase

E-ISSN： 1873-5592|6|3|337-351

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.3, 2005-05, pp. : 337-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors: from target to clinical trials

By Kelly William K O’Connor Owen A Marks Paul A

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1695-1713

Informa Healthcare

Access to resources Recommend Favorite

Towards Histone Deacetylase Inhibitors as New Antimalarial Drugs

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-08 ,pp. : 3467-3479

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis

By Contestabile Antonio Sintoni Silvia Monti Barbara

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 14-28

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 14-28

Bentham Science Publishers

Access to resources Recommend Favorite

The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. : 522-535

Bentham Science Publishers

Access to resources Recommend Favorite